Fingolimod -Response According to Coping - Evaluation
clinical trial
Press Enter · cited answer in seconds
0 sources
Fingolimod -Response According to Coping - Evaluation
Summary
Fingolimod -Response According to Coping - Evaluation is a clinical trial[1].
Key Facts
- Fingolimod -Response According to Coping - Evaluation is in the country of France[2].
- Fingolimod -Response According to Coping - Evaluation's instance of is recorded as clinical trial[3].
- Fingolimod -Response According to Coping - Evaluation's start time is recorded as +2011-08-31T00:00:00Z[4].
- Fingolimod -Response According to Coping - Evaluation's end time is recorded as +2013-06-30T00:00:00Z[5].
- Fingolimod -Response According to Coping - Evaluation's sponsor is recorded as Novartis[6].
- Fingolimod -Response According to Coping - Evaluation's main subject is recorded as anxiety disorder[7].
- Fingolimod -Response According to Coping - Evaluation's main subject is recorded as sclerosis[8].
- Fingolimod -Response According to Coping - Evaluation's main subject is recorded as multiple sclerosis[9].
- Fingolimod -Response According to Coping - Evaluation's number of participants is recorded as {'unit': '1', 'amount': '+189'}[10].
- Fingolimod -Response According to Coping - Evaluation's title is recorded as A 4-month, Prospective, Open-label, Multi-center Phase IV Study to Assess Response to Fingolimod Initiation According to Coping Profile in Adult Patients With Highly Active Relapsing Remitting Multiple Sclerosis in France[11].
- Fingolimod -Response According to Coping - Evaluation's short name is recorded as GRACE[12].
- Fingolimod -Response According to Coping - Evaluation's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[13].
- Fingolimod -Response According to Coping - Evaluation's ClinicalTrials.gov ID is recorded as NCT01420055[14].
- Fingolimod -Response According to Coping - Evaluation's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[15].
- Fingolimod -Response According to Coping - Evaluation's research intervention is recorded as fingolimod hydrochloride[16].
- Fingolimod -Response According to Coping - Evaluation's clinical trial phase is recorded as phase IV clinical trial[17].
- Fingolimod -Response According to Coping - Evaluation's research site is recorded as Novartis[18].
- Fingolimod -Response According to Coping - Evaluation's study type is recorded as interventional study[19].